Parkside Financial Bank & Trust Royalty Pharma PLC Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in Royalty Pharma PLC stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 413 shares of RPRX stock, worth $13,633. This represents 0.0% of its overall portfolio holdings.
Number of Shares
413
Previous 331
24.77%
Holding current value
$13,633
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.3 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$760 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$560 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$467 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...